Bloodwork is the only way most of the harms documented in the literature become visible before symptoms appear. Its value comes from comparison over time, which means a pre-use baseline is worth more than any single later result.
The purpose of a baseline
Reference ranges describe populations, not individuals. A result sitting inside the range can still represent a large change for a particular person, and a result slightly outside it can be entirely normal for them. Without a pre-use measurement there is no way to tell which situation you are looking at.
This is the practical argument for testing before starting anything: it converts later results from a guess into a comparison.
The core panel
Full blood count captures haematocrit and haemoglobin, which rise with androgen use and are directly relevant to clotting risk. Liver function tests capture the enzyme and bilirubin changes that precede clinically obvious liver injury in the case literature.
A fasting lipid panel matters because HDL suppression is one of the most consistent findings across the SARM and steroid literature, and it is entirely symptomless. Kidney function with electrolytes gives a reference point for later interpretation, noting that creatinine is influenced by muscle mass and supplement use.
A hormonal panel — total and free testosterone, LH, FSH, oestradiol, SHBG and prolactin — is what makes suppression and recovery measurable rather than inferred from how someone feels.
Timing
Take the baseline before starting. Retest during use at a point where change would be expected — commonly several weeks in — and again some weeks after cessation, which is the measurement most people skip and the one that answers whether the endocrine system has recovered.
Consistency of conditions matters more than people expect. Morning, fasted, and away from heavy training or a hard session the day before, because muscle damage moves liver enzymes and can look alarming for reasons unrelated to any compound.
Reading results honestly
Raised ALT and AST alone are not specific to liver injury; they rise after intense training. Raised bilirubin or GGT alongside them is more concerning, and a pattern across two tests weeks apart is more informative than any single value.
A trend that moves consistently in the wrong direction across sequential tests is meaningful even when every individual result remains within range. Interpretation belongs with a clinician who has the whole picture, including everything being taken.
What bloodwork cannot do
It does not verify what is in a product, does not detect early cardiac structural change, and does not tell you a compound is safe. Normal results mean nothing measurable has gone wrong yet at the doses used so far.
It is a monitoring tool, not a permission slip. Treating a clean panel as evidence of safety is a misreading that appears constantly in community discussion.
In short
- Test before starting; a baseline is what makes later results interpretable.
- Core panel: full blood count, liver function, fasting lipids, kidney function and a full hormonal panel.
- Retest during use and again weeks after stopping — the post-use panel is the one that shows recovery.
- Normal bloodwork indicates nothing has gone wrong yet, not that a compound is safe.
Unfamiliar terminology is defined in our glossary. How we research and grade evidence is set out in our editorial standards, and errors can be reported through corrections.
This article is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.